After the HB 121 hearing the House Judiciary Committee moved to executive action on two bills. The committee recommended House Bill 32 do pass by voice vote. HB 32, introduced by Representative Amy Riggier at the request of the Law and Justice Interim Committee, would revise circumstances in which a government entity may make an audio or video recording of a child without parental consent; committee staff summarized that change at the meeting.

The committee also considered House Bill 41, introduced by Representative Schomer at the request of the Department of Justice. HB 41 would add gabapentin to Schedule V (the list of controlled substances with the lowest federal/state scheduling), a change Department of Justice witnesses told the committee was intended to help prosecutors and law enforcement address impairment when multiple drugs are present.

Committee debate on HB 41 focused on two competing concerns: law enforcement and public safety versus patient access to needed medication. Representative Staffman said he opposed the measure because it could penalize patients taking prescribed gabapentin and create prosecutions that may follow minor impairment: "As somebody who uses this drug to survive because of back pain, I'm concerned about this bill." Representative Etchart, a medical doctor, supported the change and argued it would help law enforcement identify multi‑drug impairment: "I prescribe gabapentin all the time…people do use gabapentin for nefarious intent and also to enhance another drug."

The committee recommended HB 41 do pass and the roll call recorded 15 votes in favor and 5 opposed. Members recorded as voting yes were: Vice Chair Deming; Representatives Mitchell; Baum; Clacken; C. Hinkle; Mallett; Overstreet; Cunningham; Kometz; Sharp; Kelly; Joy; Etchart; Jay Hinkle; and Chair Regier. Members recorded as voting no were: Representatives Griffith; Zephyr; Staffman; Howell; and Vice Chair France. The committee chair announced HB 41 had passed Judiciary on that roll call.

Ending: Both bills will move to further legislative processing. The committee chair asked members to be prepared for additional executive action on Monday; HB 121 (the longer hearing earlier) remained under consideration and was not voted on that day.